Displaying items by tag: Pfizer

The EU General Court has ruled that the European Commission failed to justify its refusal to release text messages between Ursula von der Leyen and Pfizer CEO Albert Bourla regarding Covid-19 vaccine contracts. The case, brought by the New York Times, has been described as a landmark in institutional transparency. The EC had argued that texts are too ephemeral for official documentation, but the court rejected this, stating that all communication must be treated as potentially subject to public access. Critics, including the EU Ombudsman, had said that the secrecy risked favouring private interests over public welfare. Previous attempts to obtain vaccine contract details had also been met with redactions and resistance. Reacting to the decision, one commentator said, '(It is) everyone’s win as this judgment is set to lead greater accountability of EU leaders' actions’.

The war in Ukraine has taken a lot of attention away from Covid, which is unfortunate because the pandemic has now killed almost six million people. There are countries where vaccination rates are still very low; this includes most African countries, where people should not be complacent as the virus still poses a grave risk. Africa’s top public health agency has signed a memorandum of understanding with Pfizer to bring supplies of the pharmaceutical firm’s Paxlovid antiviral pills to the continent. Also Moderna will build its first facility in Rwanda to sell, package, and distribute Johnson & Johnson Covid-19 vaccines.

The UK has ordered five million doses of vaccine from the US company Moderna and 40 million of the Pfizer jab. Moderna said its vaccine may be 94.5% effective against the virus, while Pfizer suggested theirs had an efficacy of 90%. Both vaccines use the same technology which gives the vaccinated person’s body the genetic instructions for their own cells to produce the antigens and generate an immune response. The trials are ongoing and final numbers could change. Moderna vaccine is much easier to distribute than the Pfizer jab which must be kept at -100C to maintain optimal efficacy causing concerns around the storage. The Moderna vaccine lasts 30 days in household fridges, 12 hours at room temperature and remains stable at -20C (equal to most freezers) for six months. The choice has been complicated by an announcement on 19 November that the vaccine being developed by Oxford University could be ready for use by Christmas. See